The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-First Century
This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.
"1122260422"
The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-First Century
This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.
54.99 In Stock
The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-First Century

The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-First Century

by James Mittra
The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-First Century

The New Health Bioeconomy: R&D Policy and Innovation for the Twenty-First Century

by James Mittra

Paperback(1st ed. 2016)

$54.99 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores

Related collections and offers


Overview

This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.

Product Details

ISBN-13: 9781349576678
Publisher: Palgrave Macmillan US
Publication date: 01/28/2016
Edition description: 1st ed. 2016
Pages: 240
Product dimensions: 5.83(w) x 8.27(h) x (d)

About the Author

James Mittra is a Senior Research Fellow and Deputy Director of the Innogen Institute, based within Science, Technology and Innovation Studies at the University of Edinburgh, UK. He is an interdisciplinary researcher who has published widely on the bioeconomy.

Table of Contents

1. New Biology and the Foundations of a Health Bioeconomy
2. Crisis in the Pharmaceutical Industry and the Promise of New Biology
3. The 'Broken Middle' of Health Innovation
4. Organizational Transformations and the Value of Interdisciplinarity
5. Regulation, Policy and Governance of Advanced Therapies
6. The Role of Patients and Publics in Health Innovation
7. Rethinking Value and Expectations in the Health Bioeconomy
From the B&N Reads Blog

Customer Reviews